返回岗位后，我将第一时间组织中心全体人员深入学习领会两会精神，特别是关于卫生健康事业和科技 创新发展的部署要求，通过优化诊疗流程，推广适宜技术，促进优质医疗资源下沉，切实增强人民群众 在健康领域的获得感。下一步，我们将以"江苏省中医肛肠临床医学创新中心"为核心抓手，力争在年内 实现关键领域突破，产出一批具有影响力的重大临床与科研成果，切实提升江苏肛肠学科在全国的学术 地位与话语权。 （来源：新华日报） 省政协委员、南京市中医院肛肠中心主任 郑雪平 ...

市胸科医院海河院区心脏重症监护室，王霁翔带领医护团队构建的高效"绿色通道"是抢救生命的核心。 他说："对于心梗患者，救治流程的每一秒优化都意味着生存希望的显著提升。"为此，他将国际先进技 术与临床实践紧密结合，不断优化从院前到康复的全流程体系，成为患者眼中值得托付的"定心丸"。 作为一名来自卫生健康行业的人大代表，王霁翔的视野并未局限于医院之内。他总是说："健康不仅是 身体没有疾病，更包括心理与社会适应的完好状态。作为医疗界代表，推动'大健康'理念落地是我的责 任。"正因如此，他积极带领医护团队深入社区、基层，面向居民特别是公安干警、出租车司机等高压 职业群体开展健康讲座。"我们的目的很简单，就是教会大家识别风险、掌握急救方法，把健康的主动 权握在自己手里。" 王霁翔说，"我们致力于从源头构筑健康防线。" （来源：天津日报） 转自：天津日报 "时间就是心肌，时间就是生命。"这句话市胸科医院海河院区心脏重症监护室（CCU）主任王霁翔不仅 时常挂在嘴边，更是他时刻践行的信念。作为守护急性心肌梗死患者生命最后防线的医者，他带领团队 与死神赛跑；作为市人大代表，他将这份对生命的敬畏延伸至履职实践，诠释着双重身份的使命 ...

Core Insights - The 2025 Wu Jieping Medical Award and Wu Jieping Medical Innovation Award were recently presented, recognizing significant contributions in the medical field [1][2] - Notable winners include Professor Hao Xishan, an expert in oncology, and Professor Xie Lixin, an expert in ophthalmology, both of whom have made groundbreaking advancements in their respective fields [1][2] Group 1: Award Winners and Contributions - Professor Hao Xishan has dedicated over 50 years to oncology, achieving innovative results in tumor surgery, immunotherapy, and epidemiology. He pioneered the "functional interposition jejunal gastric replacement" surgery for gastric cancer, significantly improving patient quality of life and survival rates [1] - Professor Xie Lixin has focused on corneal diseases and cataract research, proposing new theories for corneal endothelial cell function assessment and conducting the first epidemiological survey of corneal diseases in China. He has developed several products to address corneal donor shortages [2] Group 2: Recognition and Future Goals - Both awardees expressed gratitude for the recognition, emphasizing the importance of their teams and the broader implications for China's medical innovation [2][3] - The Wu Jieping Medical Award evaluation committee, led by academician Han Qide, highlighted the awards' significance in improving the medical evaluation system in China and the need for ongoing efforts to enhance the awards' impact and recognition [3]

Group 1 - The second China Respiratory Health Conference was held in Guangzhou, focusing on the theme of "Collaborative Innovation in Traditional and Western Medicine: Building a New Pattern for Respiratory Health" [1] - Nearly 2000 representatives from respiratory medicine and traditional Chinese medicine participated, discussing the full-cycle management of respiratory diseases [1] - Academicians emphasized that medical innovation should lead to practical changes in clinical practice and benefit public health [1] Group 2 - The conference highlighted the importance of "collaboration between traditional and Western medicine," advocating for complementary advantages and deep integration to explore new clinical diagnosis and treatment methods [2] - Challenges such as the high incidence of respiratory diseases and the need for early diagnosis and treatment were discussed as key areas for technological innovation [2] - The conference showcased the Baiyunshan Xiaochaihu Granules, emphasizing the integration of traditional methods with modern healthcare practices [2] Group 3 - A new research-oriented pharmacy project focusing on Xiaochaihu Granules was launched, marking the first OTC drug initiative in research-oriented pharmacies in China [3] - The project aims to create high-quality pharmacies that collect health-related information and feedback, promoting active participation in health management [3] Group 4 - The "2026 Traditional Chinese Medicine Respiratory Health Development Community" was officially launched, focusing on the full-cycle management of respiratory diseases [4] - The community aims to conduct evidence-based medical research and promote suitable technologies, supporting the establishment of a national respiratory disease prevention network [4] - Several key documents and guidelines were released during the conference, including expert consensus on chronic obstructive pulmonary disease and a white paper on respiratory health strategies [4]

Core Insights - The 2025 "Honorary Doctors" and "National Famous Doctors" awards highlight the achievements of Chinese medical professionals in overcoming difficult medical challenges and advancing medical technology and research [1][2][3] Group 1: Medical Innovation - Medical innovation is rooted in clinical practice, emerging from every patient consultation and surgical breakthrough [2][3] - The focus of medical innovation is to address patient pain and improve their quality of life, rather than merely pursuing advanced technology for its own sake [2][3] Group 2: Clinical Practice and Patient Care - Clinical innovation is driven by the need to enhance surgical precision, reduce recovery time, and optimize patient experience [3][5] - Successful case studies, such as the development of a minimally invasive eye surgery technique, demonstrate the impact of clinical innovation on patient outcomes [3][5] Group 3: Future Directions in Healthcare - The integration of artificial intelligence in medicine is reshaping healthcare delivery, extending the role of doctors beyond hospitals to community and home settings [6] - Key future pillars of medical development include precision prevention, innovative drugs, minimally invasive interventions, and organ transplantation [6]

Group 1 - The Beijing Municipal Government has launched the "Beijing Action Plan for Promoting the Transformation of Scientific and Technological Achievements (2025-2027)" to enhance medical innovation and research [1] - The Beijing Municipal Health Commission has initiated an excellent clinical research program for research-type wards, investing 200 million yuan to support 30 projects across 25 hospitals, focusing on 12 key diseases [1] - The Health Commission has developed three governance tools to analyze disease burden, compare domestic and international treatment levels, and identify unmet clinical needs, resulting in the identification of 100 major medical technology issues in the capital [1] Group 2 - In October 2022, Beijing introduced a pilot program for medical innovation and achievement transformation at hospitals, with 24 pilot projects covering innovative medical devices, drugs, and digital therapies [2] - The pilot projects include internationally pioneering solutions such as 3D-printed skull plates and new therapies for stroke and mental health [2] - The government has released a 2.0 version of the pilot program, emphasizing increased funding from hospitals, accelerated data value transformation, and improved decision-making processes to enhance the efficiency of technology transfer [2]

Core Insights - The 8th China International Import Expo (CIIE) opened on November 5, showcasing Roche's commitment to innovation and life protection with over 40 products and diverse innovative solutions [1][3] - Roche's participation highlights the importance of CIIE as a strategic platform for foreign enterprises to engage with the Chinese market and share global innovations [5] Group 1: Roche's Participation - Roche Pharmaceuticals held the "2025 Roche Pharmaceuticals 8th CIIE Opening Ceremony" and presented its complete pharmaceutical value chain in China for the first time [1] - The company showcased more than 10 products that will soon be launched in China, covering various disease areas including breast cancer, hematology, neuroscience, ophthalmology, immunology, cardiovascular, and metabolism [5] Group 2: CIIE's Role - The CIIE serves as a key platform for China to open its market and promote global cooperation, focusing on high-quality exhibitors and innovative products [3] - Over the past eight years, the CIIE has facilitated the transformation of nearly 15 Roche global innovative drugs from exhibits to market-ready products, benefiting Chinese patients [5] Group 3: Innovative Solutions - Roche's exhibition included immersive creative interactive installations to enhance public understanding of medical innovations and humanistic care [5] - The company also presented various AI solutions that span research, diagnosis, and patient management, aiming to empower the entire diagnostic and treatment process [5]

Core Insights - Fudan University has received approval to establish the Hongqiao Medical Innovation Park, which is expected to be completed around 2030, located in the Hongqiao International Central Business District [1] - The park will serve as a comprehensive innovation hub integrating education, research, industry, and services, aiming to align with world-class medical centers and enhance the integration of medical and industrial resources [1][2] Group 1 - The Hongqiao Medical Innovation Park will consist of five plots and is strategically positioned within the core area of the Hongqiao International Open Hub [1] - The park aims to create an integrated experimental zone for medical education and technology talent, a full-chain gathering area for the biopharmaceutical industry, and high-level international medical services [1][2] Group 2 - The establishment of the park is not merely an expansion of space but a strategic move to position Fudan University as a leader in new medical disciplines and interdisciplinary integration [2] - The park will focus on cutting-edge fields such as biomedicine, artificial intelligence, and biomedical engineering, facilitating seamless connections between basic research, clinical transformation, and industrial application [2] Group 3 - The park will leverage Fudan University's multidisciplinary strengths to advance in emerging fields like intelligent medicine and brain-machine interfaces, while also expanding into areas such as genetic medicine, cell and gene therapy, and vaccine safety [3]

Group 1 - The 8th China International Import Expo (CIIE) opened on November 5, showcasing Roche's commitment to innovation and life protection with over 40 products and innovative solutions [1][2] - Roche's participation in CIIE has facilitated the transformation of nearly 15 global innovative drugs into marketable products in China, benefiting local patients [2] - Roche's exhibition includes upcoming products in various disease areas such as breast cancer, hematology, neuroscience, ophthalmology, immunology, cardiovascular, and metabolism [2][3] Group 2 - The CIIE serves as a key platform for China's market openness and global cooperation, emphasizing high-quality exhibitors and innovative products [2] - Roche's exhibition features immersive interactive installations and a "healing space" to enhance public engagement with medical innovations and humanistic care [2] - During the expo, Roche and its partners held over ten conferences focusing on digital healthcare and medical innovation, showcasing the latest clinical advancements and cross-sector collaboration [3]

Core Viewpoint - The article highlights the advancements in medical technology, particularly brain-computer interface (BCI) technology, and its applications in patient rehabilitation, as well as the importance of healthy lifestyle habits in preventing cardiovascular diseases. Group 1: Brain-Computer Interface Technology - BCI technology aims to reconnect the disrupted communication pathways between the brain and limbs in patients with conditions like stroke, enabling them to regain motor functions [7][8] - The technology involves capturing brain signals through invasive methods (implanting electrodes) or non-invasive methods (using special helmets to read brain waves) [7][8] - Current research focuses on helping patients achieve motor rehabilitation, language reconstruction, and visual restoration, allowing paralyzed patients to control devices like robotic arms or wheelchairs through thought [8][9] Group 2: Cardiovascular Health and Lifestyle - Cardiovascular diseases are a major health threat in China, closely linked to poor lifestyle choices such as high salt, oil, and sugar intake, excessive alcohol consumption, smoking, and lack of sleep [11][12] - Recommendations for improving cardiovascular health include reducing salt intake to less than 5 grams per day, oil to 25-30 grams, and sugar to less than 25 grams, while increasing the consumption of vegetables, fruits, and whole grains [12] - Emphasizing the importance of integrating physical activity into daily routines and maintaining mental well-being as part of a healthy lifestyle [12] Group 3: Medical Ethics and Education - The cultivation of medical ethics and skills is essential for healthcare professionals, with a focus on integrating ethical training with clinical practice [14][15] - Young medical professionals should be encouraged to develop empathy, communication skills, and a strong sense of responsibility towards patients [15] - The article advocates for a supportive environment for healthcare workers, emphasizing the need for continuous learning and experience accumulation to enhance patient care [19]